Efficacy of Reduction of the Balloon Volume for Prevention of Postoperative Catheter-related Bladder Discomfort in Patients Undergoing Non-lower Urinary Tract Surgery
1 other identifier
interventional
120
0 countries
N/A
Brief Summary
CRBD is related to different degrees of irritation caused by the volume of the balloon in the urinary catheter, and when CRBD occurs, it may cause severe postoperative pain and trauma by self-removal of the catheter, further leading complications. Although many drugs can improve CRBD, measures that can be immediately intervened by non-nursing staff at any time and even have different side effects on patients due to drug use.Therefore, the author wants to use this study to explore the reduction of catheter balloon volume can effectively reduce the degree of CRBD, is a non-invasive and immediately executable nursing treatment.the quality of clinical care and hospitalization of the patient can be further improved, reducing the patient's inappropriate, thereby improving the quality of medical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2023
CompletedFirst Posted
Study publicly available on registry
September 14, 2023
CompletedStudy Start
First participant enrolled
September 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedSeptember 21, 2023
May 1, 2023
3 months
September 8, 2023
September 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Degree of Catheter-related Bladder Discomfort
Likert scale 0.1.2.3,the minimum value is 0 and the maximum value is 3. The larger the number, the more serious the discomfort is.
Return to the ward after surgery 0 hours.3 hours.12 hours
Secondary Outcomes (1)
Visual analog scale for pain severity
Return to the ward after surgery 0 hours.3 hours.12 hours
Study Arms (2)
Effect of normal 10ml balloon volume on postoperative CRBD in non-LUTS patients
ACTIVE COMPARATOREfficacy of normal 10ml balloon volume for prevention of postoperative catheter-related bladder discomfort in patients undergoing non-lower urinary tract surgery
Effect of reduction of 5ml balloon volume for postoperative CRBD in patients undergoing non-LUTS
ACTIVE COMPARATOREfficacy of reduction of 5ml the balloon volume for prevention of postoperative catheter-related bladder discomfort in patients undergoing non-lower urinary tract surgery
Interventions
The investigators will collect 120 participants divided into two groups ,in different procedure(stone procedure, herniarraphy, nephrectomy), and the investigators used different urinary catheter balloon size(10ml and 5ml), tp investigate the patient with the severity of catheter-related bladder discomfort.
Eligibility Criteria
You may qualify if:
- age from 20-80 year-old
- in urological surgery under the general anesthesia
- arms: (1)non-lower urinary tract surgery: hernia, and nephrectomy surgery , (2) lower urinary tract surgery: stone surgery after ureter catheter insertion.
You may not qualify if:
- Patients not undergoing hernia repair or nephrectomy.
- Patients who are not undergoing ureteral lithotripsy and renal stone extraction.
- Those who are already using drugs for overactive bladder or prostatic hypertrophy.
- Retrograde intrarenal surgery (RIRS) for stone extraction.
- People with dementia.
- Patients with cognitive impairment.
- Patients with impaired consciousness.
- Patients who are unable to communicate verbally.
- The subject had participated in other experimental drug trials one month before the study entered.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2023
First Posted
September 14, 2023
Study Start
September 18, 2023
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
September 21, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share